Who founded Avery Therapeutics?

Avery Therapeutics was founded by Jennifer Koevary, Steven Goldman, Jordan Lancaster in 2015.

How much funding has Avery Therapeutics raised?

Avery Therapeutics has disclosed $500K raised across 1 of its 2 known rounds.

Where is Avery Therapeutics headquartered?

Avery Therapeutics is headquartered in Tucson, US.

Avery Therapeutics

Tucson, US · Founded 2015 · Arizona corporation · 9 employees on LinkedIn

Find your way into Avery Therapeutics

160 people in our graph share verified history with the Avery Therapeutics team — schools, employers, funds. One of them is your warm intro.

Jeffrey Finerunlockedknows Steven Goldman · together at Stanford University School of Medicine

×11knows the team · via Stanford University School of Medicine

Avery Therapeutics is a biotechnology company focused on developing immunomodulatory biologic therapeutics. It is led by an executive team and supported by a board of directors and a scientific and medical advisory board.

Biotech

Founders & leadership

Avery Therapeutics was founded in 2015 by Jennifer Koevary, Steven Goldman, and Jordan Lancaster.

Jennifer KoevaryCo-founder

Steven Goldman inChief Medical Officer, Co-FounderA board-certified cardiologist with over 30 years of clinical and research experience, he holds an M.D. from the University of Cincinnati and completed internal medicine and cardiology training at the University of Illinois, University of Chicago, Stanford, and Presbyterian Pacific Medical Center.

Jordan LancasterinCo-founder · Chief Executive Officer

Lawrence MehrenNamed on SEC filing

Emile NuwaysirNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$500K disclosed across 1 of 2 rounds · 2017–2026

▶$8.5MraisedSep 2026 · 23 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Jordan LancasterExecutive Officer, Director
Lawrence MehrenDirector
Emile NuwaysirDirector
Steven GoldmanExecutive Officer

Offering amount: $15.4M
Amount sold: $8.5M
First sale: Aug 2026
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$500KraisedJun 2017 · 16 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Jennifer KoevaryExecutive Officer
Steven GoldmanExecutive Officer
Jordan LancasterExecutive Officer

Offering amount: $1.5M
Amount sold: $500K
Minimum investment: $25K
First sale: May 2017
Incorporated: Corporation, Arizona, 2015
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Veratx7 shared keywordsVera Therapeutics develops medicines targeting autoimmune-driven kidney diseases, with a focus on reducing the need for dialysis or transplant. The company was founded by a physician and operates as a clinical-stage biotech with a patient-centered approach to drug development.

Relay7 shared keywordsRelay Therapeutics develops the Dynamo platform, which applies motion-based drug design principles to discover therapeutic drugs by integrating protein dynamics simulations with experimental and computational techniques. The platform serves pharmaceutical and biotech researchers seeking to accelerate drug discovery across multiple phases of development.

Companies competing with Avery Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Institutes of Health (NIH)National Institutes of Health	Phase I	2019	$300K
National Institutes of Health (NIH)National Institutes of Health	Phase I	2016	$484K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Avery Therapeutics, Inc. announced that it has received $320 million in funding from a group of investorsmarketscreener.com · Jul 2026

Frequently asked questions

What does Avery Therapeutics do?: Avery Therapeutics is a biotechnology company focused on developing immunomodulatory biologic therapeutics. It is led by an executive team and supported by a board of directors and a scientific and medical advisory board.
Who founded Avery Therapeutics?: Avery Therapeutics was founded by Jennifer Koevary, Steven Goldman, Jordan Lancaster in 2015.
How much funding has Avery Therapeutics raised?: Avery Therapeutics has disclosed $500K raised across 1 of its 2 known rounds.
Where is Avery Therapeutics headquartered?: Avery Therapeutics is headquartered in Tucson, US.